Publications by authors named "Gerald Spotts"

Claim this Profile
R
Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgery.
Ingrid Pabinger, Vasily Mamonov, Jerzy Windyga, Werner Engl, Jennifer Doralt, Gerald Spotts

Haemophilia· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postauthorization safety surveillance study of antihaemophilic factor (recombinant) reconstituted in 2 mL sterile water for injection in children with haemophilia A.
Jayashree Motwani, Benoit Guillet, Jan Blatny, Freimut H Schilling, Bénédicte Wibaut, Gerald Spotts

Haemophilia· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling to Predict Factor VIII Levels Associated with Zero Bleeds in Patients with Severe Hemophilia A Initiated on Tertiary Prophylaxis.
Pratima Chowdary, Kathelijn Fischer, Peter W Collins, Amy Cotterill, Barbara A Konkle, Gerald Spotts

Thromb Haemost· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Rapid Progressing Allele HLA-B35 Px Restricted Anti-HIV-1 CD8+ T Cells Recognize Vestigial CTL Epitopes.
Christian B Willberg, Keith E Garrison, R Brad Jones, Duncan A Meiklejohn, Gerald Spotts

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing personalized care in hemophilia A: ten years' experience with an advanced category antihemophilic factor prepared using a plasma/albumin-free method.
Erik Berntorp, Gerald Spotts, Lisa Patrone, Bruce M Ewenstein

Biologics· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaques.
Stéphane Champiat, Keith E Garrison, Rui André Saraiva Raposo, Benjamin J Burwitz, Jason Reed, Gerald E Spotts

J Virol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylaxis and quality of life in patients with hemophilia A during routine treatment with ADVATE [antihemophilic factor (recombinant), plasma/albumin-free method] in Germany: a subgroup analysis of the ADVATE PASS post-approval, non-interventional study.
Hartmut Pollmann, Robert Klamroth, Natascha Vidovic, Alexander Y Kriukov, Joshua Epstein, Gerald Spotts

Ann Hematol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection.
Stephane Champiat, Rui André Saraiva Raposo, Nicholas J Maness, John L Lehman, Sean E Purtell, Gerald E Spotts

PLoS One· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight.
Sven Björkman, MyungShin Oh, Gerald Spotts, Phillip Schroth, Sandor Fritsch

Blood· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.
Devi SenGupta, Ravi Tandon, Raphaella G S Vieira, Lishomwa C Ndhlovu, Rachel Lown-Hecht, Gerald Spotts

J Virol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes.
Christian B Willberg, Keith E Garrison, R Brad Jones, Duncan A Meiklejohn, Gerald Spotts

PLoS One· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune escape mutations detected within HIV-1 epitopes associated with viral control during treatment interruption.
Becky Schweighardt, Terri Wrin, Duncan A Meiklejohn, Gerald Spotts, Christos J Petropoulos

J Acquir Immune Defic Syndr· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection.
R Brad Jones, Lishomwa C Ndhlovu, Jason D Barbour, Prameet M Sheth, Aashish R Jha, Gerald Spotts

J Exp Med· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection.
Lishomwa C Ndhlovu, Christopher P Loo, Gerald Spotts, Douglas F Nixon, Frederick M Hecht

J Leukoc Biol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.
Jakob Michaëlsson, Brian R Long, Christopher P Loo, Lewis L Lanier, Gerald Spotts

J Infect Dis· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell responses to human endogenous retroviruses in HIV-1 infection.
Keith E Garrison, R Brad Jones, Duncan A Meiklejohn, Naveed Anwar, Lishomwa C Ndhlovu, Gerald Spotts

PLoS Pathog· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point.
John W Northfield, Christopher P Loo, Jason D Barbour, Gerald Spotts, Frederick M Hecht

J Virol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.
Annika C Karlsson, Astrid K N Iversen, Joan M Chapman, Tulio de Oliviera, Gerald Spotts

PLoS One· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance.
Grant Nash Colfax, Eric Vittinghoff, Robert Grant, Paula Lum, Gerald Spotts

AIDS· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection.
Philip J Norris, Brandee L Pappalardo, Brian Custer, Gerald Spotts, Frederick M Hecht

AIDS Res Hum Retroviruses· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2.
Markus Moll, Jennifer Snyder-Cappione, Gerald Spotts, Frederick M Hecht, Johan K Sandberg

Blood· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability of ADVATE, Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method, during simulated continuous infusion.
Maximilian Fernandez, Tabitha Yu, Erik Bjornson, Huong Luu, Gerald Spotts

Blood Coagul Fibrinolysis· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis